| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.26 | 0.05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |